Articles from Rinri Therapeutics Ltd.

Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows

Elevating the importance of neural health via better diagnosis and treatment is crucial for restoration of natural hearing, JARO review concludes

By Rinri Therapeutics Ltd. · Via GlobeNewswire · April 21, 2026

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss

Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist

By Rinri Therapeutics Ltd. · Via GlobeNewswire · July 1, 2025